PL2135091T3 - Sposoby spektrometrii mas w analizie glikanów - Google Patents

Sposoby spektrometrii mas w analizie glikanów

Info

Publication number
PL2135091T3
PL2135091T3 PL08745856T PL08745856T PL2135091T3 PL 2135091 T3 PL2135091 T3 PL 2135091T3 PL 08745856 T PL08745856 T PL 08745856T PL 08745856 T PL08745856 T PL 08745856T PL 2135091 T3 PL2135091 T3 PL 2135091T3
Authority
PL
Poland
Prior art keywords
glycans
methods
evaluate
things
identification
Prior art date
Application number
PL08745856T
Other languages
English (en)
Inventor
Carlos J Bosques
Nathaniel J Washburn
Xiangping Zhu
Ian Christopher Parsons
Original Assignee
Momenta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals Inc filed Critical Momenta Pharmaceuticals Inc
Publication of PL2135091T3 publication Critical patent/PL2135091T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL08745856T 2007-04-16 2008-04-15 Sposoby spektrometrii mas w analizie glikanów PL2135091T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92367707P 2007-04-16 2007-04-16
EP08745856A EP2135091B1 (en) 2007-04-16 2008-04-15 Ms methods to evaluate glycans
PCT/US2008/060334 WO2008128221A1 (en) 2007-04-16 2008-04-15 Ms methods to evaluate glycans

Publications (1)

Publication Number Publication Date
PL2135091T3 true PL2135091T3 (pl) 2011-11-30

Family

ID=39615678

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08745856T PL2135091T3 (pl) 2007-04-16 2008-04-15 Sposoby spektrometrii mas w analizie glikanów

Country Status (14)

Country Link
US (1) US8043863B2 (pl)
EP (1) EP2135091B1 (pl)
JP (1) JP5116837B2 (pl)
AT (1) ATE512366T1 (pl)
AU (1) AU2008240074B2 (pl)
CA (1) CA2682750A1 (pl)
CY (1) CY1111811T1 (pl)
DK (1) DK2135091T3 (pl)
ES (1) ES2367210T3 (pl)
HR (1) HRP20110610T1 (pl)
PL (1) PL2135091T3 (pl)
PT (1) PT2135091E (pl)
SI (1) SI2135091T1 (pl)
WO (1) WO2008128221A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135091B1 (en) 2007-04-16 2011-06-08 Momenta Pharmaceuticals, Inc. Ms methods to evaluate glycans
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
WO2014018747A2 (en) 2012-07-26 2014-01-30 Momenta Pharmaceuticals, Inc. Glycoproteins with anti-inflammatory properties
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
EP2991666B1 (en) 2013-05-02 2020-03-25 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
EP3058084A4 (en) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
EP4310503A3 (en) 2015-12-30 2024-03-20 Momenta Pharmaceuticals, Inc. Methods related to biologics
CN113286650A (zh) 2018-09-06 2021-08-20 动量制药公司 连续细胞培养方法
JP2022502466A (ja) 2018-10-11 2022-01-11 モメンタ ファーマシューティカルズ インコーポレイテッド 高度にシリル化されたＩｇＧ組成物による処理
KR20210131323A (ko) 2018-12-31 2021-11-02 모멘타 파머슈티컬스 인코포레이티드 우스테키누맙 생성 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3383587B2 (ja) 1998-07-07 2003-03-04 株式会社東芝 静止画像連続情報記録方法と光ディスクと光ディスクの情報再生装置と情報再生方法
US7575886B2 (en) * 2002-03-11 2009-08-18 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
WO2004066808A2 (en) * 2002-12-20 2004-08-12 Momenta Pharmaceuticals, Inc. Glycan markers for diagnosing and monitoring disease
JP4727577B2 (ja) * 2003-07-03 2011-07-20 ウオーターズ・テクノロジーズ・コーポレイシヨン 同位体組成および質量分析システムおよび方法
US7138228B2 (en) 2003-09-05 2006-11-21 Regents Of The University Of California Protein O-sulfonation
US20060057638A1 (en) 2004-04-15 2006-03-16 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
US20090012714A1 (en) * 2004-08-04 2009-01-08 Yasushi Ishihama Test of amino acid sequence constituting peptide using isotopic ratio
JP2006047239A (ja) * 2004-08-09 2006-02-16 National Institute Of Advanced Industrial & Technology 硫酸化単糖の同定方法及び硫酸化単糖異性体混合物の分析方法
US20090114809A1 (en) * 2005-09-02 2009-05-07 Australian Nuclear Science & Technology Organisation Isotope ratio mass spectrometer and methods for determining isotope ratios
EP2135091B1 (en) 2007-04-16 2011-06-08 Momenta Pharmaceuticals, Inc. Ms methods to evaluate glycans

Also Published As

Publication number Publication date
EP2135091B1 (en) 2011-06-08
SI2135091T1 (sl) 2011-10-28
JP5116837B2 (ja) 2013-01-09
HRP20110610T1 (hr) 2011-10-31
EP2135091A1 (en) 2009-12-23
ES2367210T3 (es) 2011-10-31
ATE512366T1 (de) 2011-06-15
US8043863B2 (en) 2011-10-25
US20100133430A1 (en) 2010-06-03
AU2008240074B2 (en) 2013-02-21
CA2682750A1 (en) 2008-10-23
CY1111811T1 (el) 2015-10-07
PT2135091E (pt) 2011-09-01
AU2008240074A1 (en) 2008-10-23
JP2010525327A (ja) 2010-07-22
DK2135091T3 (da) 2011-09-19
WO2008128221A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
SI2135091T1 (sl) MS postopki za evaluacijo glikanov
MX2010005888A (es) Anticuerpos bivalentes biespecificos.
MX2010006396A (es) Anticuerpos bivalentes, biespecificos.
UA100874C2 (en) Bivalent bispecific antibodies
MX340558B (es) Anticuerpos biespecificos que comprenden fragmento fv estabilizado con disulfuro.
MX338711B (es) Pirrolobenzodiazepinas y conjugados de las mismas.
UY33703A (es) Anticuerpos anti-il-23
MY161909A (en) Anti-her3 antibodies and uses thereof
MX366303B (es) Pirrolobenzodiazepinas y conjugados de las mismas.
MX2011010012A (es) NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS.
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
MY162901A (en) Surface-treated calcium carbonate for binding and bioremediating hydrocarbon-containing compositions
MY155330A (en) Methods for salt production
ATE532814T1 (de) Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen
SG145667A1 (en) Chronograph watch
MX2011011623A (es) Antagonistas del receptor tipo toll 3.
MX2012010317A (es) ß-HIDROXIALQUILAMIDAS, METODO PARA SU PRODUCCION Y SU USO.
MX362457B (es) Antagonistas del receptor tipo toll 3.
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
AR123070A2 (es) Anticuerpos anti-il-23
UA34276U (ru) 7-β-ГИДРОКСИЭТИЛ-3-МЕТИЛ-8-N-ПИРРОЛИДИНОКСАНТИН, КОТОРЫЙ ПРОЯВЛЯЕТ ДИУРЕТИЧЕСКОЕ ДЕЙСТВИЕ
UA29068U (ru) Способ изготовления конструкционной смеси "ПЕНОРЕЗОЛ"
UA65321U (en) Binder
AU323946S (en) Tumbler
UA71312U (uk) N-β-ГІДРОКСІЕТИЛБЕНЗИЛАМОНІЮ 3,7-ДИМЕТИЛІМІДАЗО [1,2-f]КСАНТИНІЛ-8-ПРОПАНОАТ, ЯКИЙ ВИЯВЛЯЄ АНАЛЬГЕТИЧНУ ДІЮ